Indonesia's BPOM Issues New Regulation, Updating Cosmetic Ingredient Requirements
Published: Author: Visits: 19064

On October 3, 2025, the National Agency of Drug and Food Control (BPOM) of Indonesia officially enacted the Technical Requirements for Cosmetic Ingredients (Regulation No. 25 of 2025), which comprehensively updates the usage standards for cosmetic ingredients. According to the regulatory provisions, the previously implemented Regulation No. 23 of 2019 and Regulation No. 17 of 2022 are simultaneously repealed.

Indonesia,Cosmetic,Ingredient,Update,BPOM

This regulation comes into effect on the date of its enactment and includes a 12-month transition period. CIRS advises relevant companies to promptly conduct reviews of existing product formulations, labeling content, and other aspects to ensure continued compliant market placement of products.

Key changes include:

  • Lampiran I (List of Restricted Ingredients): Updated concentration limits and usage conditions for Salicylic Acid, Zinc Pyrithione, Acid Yellow 3, Etidronic Acid, and BHT (Butylated Hydroxytoluene).
  • Lampiran IV (List of Permitted UV Filters): Revised restrictions on Benzophenone-3 and Homosalate.
  • Lampiran V (List of Prohibited Ingredients): Addition of Lilial (Butylphenyl Methylpropional), D4 (Octamethylcyclotetrasiloxane), Styrene, and Quaternium-15 to the banned list.

Our Services

  • Indonesian Company License Holding Service;
  • BPOM Account Registration in Indonesia;
  • Formula and Packaging Review;
  • Cosmetic Product Notification in Indonesia;
  • Preparation and Compilation of PIF/DIP Files;
  • Product Testing Services;
  • Logistics and Customs Clearance;
  • HALAL Certification.

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

Further Information

https://jdih.pom.go.id/download/rule/1697/25/2025/Peraturan%20Badan%20Pengawas%20Obat%20dan%20Makanan%20Nomor%2025%20Tahun%202025%20tentang%20Persyaratan%20Teknis%20Bahan%20Kosmetik

Disclaimer :
CIRS accepts no responsibility or liability whatsoever with regard to the information on this website. Reproduction for non-commercial purposes of information and documents from the our website is authorised provided that you acknowledge "CIRS" as the source.